Ticker Details
RenovoRx, Inc.
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$33.35M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 4.64%
Avg Daily Range (30 D):	$0.03 | 2.66%
Avg Daily Range (90 D):	$0.04 | 3.83%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.28M

Trade Size
Avg Trade Size (Sh.):	208
Avg Trade Size (Sh.) (30 D):	477
Avg Trade Size (Sh.) (90 D):	425

Institutional Trades
Total Institutional Trades:	8
Avg Institutional Trade:	$1.13M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Jun 26, 2024 @ 12:30 PM University of Nebraska Medical Center Launches Pat... Source: RenovoRx, Inc.

Jun 10, 2024 @ 12:30 PM RenovoRx Appoints Ryan Witt as Senior Vice Preside... Source: RenovoRx, Inc.

Jan 2, 2024 @ 6:35 PM Why Longboard Pharmaceuticals Shares Are Trading H... Source: Avi Kapoor

Dec 28, 2023 @ 6:07 PM Why DouYu International Shares Are Trading Higher ... Source: Avi Kapoor

Jun 30, 2023 @ 10:00 AM What to Look for in a Penny Stocks Trading Platfor... Source: D. Marie

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.36	$-.08	$-.08
Diluted EPS	$-.36	$-.08	$-.08
Revenue	$.63M	$.21M	$.27M
Gross Profit
Net Income / Loss	$-11.11M	$-2.91M	$-2.9M
Operating Income / Loss	$-11.62M	$-3.2M	$-2.68M
Cost of Revenue
Net Cash Flow	$5.98M	$M	$M
PE Ratio